Roivant Sciences Ltd.
ROIV· Nasdaq
ROIVRoivant Sciences Ltd.
Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001140361-22-041175
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $12.53M | $13.99M | $1.32M |
| Net Income | -$291.59M | -$208.48M | -$35.40M |
| EPS Diluted | -$0.42 | -$0.32 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Roivant Sciences Ltd. · CIK 1635088 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end
